TCM
MRTX

TimesSquare Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

TimesSquare Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-241,300
Closed -$17.7M – 237
2019
Q1 		$17.7M Buy
+241,300
New +$17.7M 0.14% 183